Trials / Unknown
UnknownNCT05793645
Clinical Investigation to Assess the Feasibility of a New Diabetes Management Program
Clinical Investigation to Assess the Feasibility of a New Diabetes Management Program, the dALi System, for Pediatric Type 1 Diabetes (T1D) Subjects
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Air Liquide Santé International · Industry
- Sex
- All
- Age
- 12 Years – 15 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this interventional study is to assess the adherence to a personalized care plan in patients (12-15 years) with Type 1 diabetes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | personalized care plan | Algorithm that defines personalized care plan |
Timeline
- Start date
- 2023-05-15
- Primary completion
- 2024-01-30
- Completion
- 2024-03-30
- First posted
- 2023-03-31
- Last updated
- 2023-07-20
Locations
3 sites across 1 country: Sweden
Source: ClinicalTrials.gov record NCT05793645. Inclusion in this directory is not an endorsement.